Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
26 September 2023 | Story Lunga Luthuli | Photo Supplied
Imtiaz Sooliman
Dr Imtiaz Sooliman, founder of the Gift of the Givers Foundation, speaks at a University of the Free State Brown Bag Lunch, sharing insights on how postgraduate education can empower individuals to bring hope and change to those around them.

The University of the Free State (UFS) Centre for Graduate Support (CGS) recently hosted Dr Imtiaz Sooliman, founder of the Gift of the Givers Foundation, at a CGS Brown Bag Lunch. The Brown Bag Lunches are a series of informal talks aimed at providing guidance and inspiration to postgraduate students.  

The event served as a platform for Dr Sooliman to share his insights into how pursuing a postgraduate degree can empower individuals to bring hope and change to those around them.

He said his talk was inspired by his own journey: “After receiving a message from my spiritual leader in Istanbul, Turkey, at the age of just 30, I immediately heeded the calling and established the Gift of the Givers Foundation.”

He emphasised that success and progress are not possible without faith and spirituality, and that these were motivating factors in his work. “The foundation works to unite people with a common vision to make a real difference by serving mankind for the greater good.”

Dr Sooliman shared many of his experiences and insights with the audience. He said the foundation has provided critical aid to many disaster-stricken regions and has extended its assistance to the most vulnerable populations worldwide.

Creating hope 

The Gift of the Givers Foundation also provides support to the UFS No Student Hungry Programme, which delivers food parcels to needy students on the UFS’s three campuses.  

Dr Sooliman’s efforts have helped the foundation make a real and telling difference in the lives of people from all classes, political affiliations, and geographical locations

He encouraged students and academics in the audience to “view your pursuit of higher education as a means to gain knowledge, but also as a tool to cultivate empathy, resilience, and a sense of purpose”.

Event organisers said the University of the Free State continues to promote education and community engagement, and Dr Sooliman’s visit served as a beacon of inspiration for students and academics alike.

Dr Danila Wessels, Assistant Director at the Centre for Graduate Support, said, “Inviting Dr Imtiaz Sooliman to our Brown Bag Lunch event was a deliberate choice driven by our commitment to broadening the vision of UFS postgraduate students. We believe that postgraduate studies can serve as a powerful impetus for bringing hope to people, and Dr Sooliman's inspirational journey perfectly exemplifies this." 

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept